DRKS00024454
Completed
未知
Randomized, placebo-controlled clinical trial on the efficacy of a mouthrinse containing 0.1% benzalkoniumchloride on the reduction of intraoral viral load and infectivity in SARS-CoV-2 positive subjects (COVID-19)
Poliklinik für Zahnerhaltung und ParodontologieUniversitätsklinikum Regensburg0 sites24 target enrollmentFebruary 8, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- U07.1
- Sponsor
- Poliklinik für Zahnerhaltung und ParodontologieUniversitätsklinikum Regensburg
- Enrollment
- 24
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •positive SARS\-CoV\-2 detection within the last 72 h
Exclusion Criteria
- •\- Indication for intubation or mechanical ventilation
- •\- severe stomatitis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Randomised, placebo-controlled clinical trial on the efficacy of Roleca® juniper 100 mg for dyspeptic digestive complaints such as cramps in the gastrointestinal tract, flatulence and bloating.Treatment of dyspeptic digestive complaints (cramps in the gastrointestinal tract, flatulence, bloating).Therapeutic area: Diseases [C] - Digestive System Diseases [C06]CTIS2023-504750-35-01CGBS GbR100
Not yet recruiting
Phase 1
Randomized, Placebo-Controlled Clinical Trial of Transdermal dihydrotestosterone Gel to Improve In Vitro Fertilization Outcomes In Women With Poor Ovarian ResponseACTRN12615001115527Prof.David Handelsman242
Completed
Not Applicable
Imiquimod Plus Antimony Immunochemotherapy for Cutaneous LeishmaniasisPER-065-05DRUGS FOR NEGLECTED DISEASE INITIATIVE,
Active, not recruiting
Phase 1
A Study to Test the Effects of Exenatide Once Weekly on Cardiovascular Outcomes in Patients with Type 2 DiabetesType 2 diabetes mellitusMedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2010-021069-63-SKAmylin Pharmaceuticals, LLC14,000
Completed
Phase 3
A randomized, placebo, controlled clinical trial to evaluate cardiovascular outcomes after treatment with Exenatide Once Weekly in patients with type 2 diabetes mellitusnon-insulin dependent diabetesType 2 diabetes mellitus10018424NL-OMON41366Amylin Pharmaceuticals, LLC204